Latest & greatest articles for headache

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on headache or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on headache and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for headache

81. The cost effectiveness of onabotulinumtoxinA for the prophylaxis of headache in adults with chronic migraine in the UK

The cost effectiveness of onabotulinumtoxinA for the prophylaxis of headache in adults with chronic migraine in the UK The cost effectiveness of onabotulinumtoxinA for the prophylaxis of headache in adults with chronic migraine in the UK The cost effectiveness of onabotulinumtoxinA for the prophylaxis of headache in adults with chronic migraine in the UK Batty AJ, Hansen RN, Bloudek LM, Varon SF, Hayward EJ, Pennington BW, Lipton RB, Sullivan SD Record Status This is a critical abstract (...) of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. CRD summary This study evaluated the cost-effectiveness of botulinum neurotoxin type A (onabotulinumtoxinA) to prevent headache in adults with chronic migraine. The authors concluded that onabotulinumtoxinA was cost-effective for the UK NHS

NHS Economic Evaluation Database.2013

82. Is Subcutaneous Sumatriptan an Effective Treatment For Adults Presenting to the Emergency Department With Acute Migraine Headache?

Is Subcutaneous Sumatriptan an Effective Treatment For Adults Presenting to the Emergency Department With Acute Migraine Headache? DEFINE_ME_WA This site requires Cookies to be enabled to function. Please ensure Cookies are turned on and then re-visit the desired page.

Annals of Emergency Medicine Systematic Review Snapshots2013

83. Randomised controlled trial: Acupuncture prophylaxis of migraine no better than sham acupuncture for decreasing frequency of headaches

Randomised controlled trial: Acupuncture prophylaxis of migraine no better than sham acupuncture for decreasing frequency of headaches Acupuncture prophylaxis of migraine no better than sham acupuncture for decreasing frequency of headaches | Evidence-Based Medicine This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user (...) name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Acupuncture prophylaxis of migraine no better than sham acupuncture for decreasing frequency of headaches Article Text Therapeutics Randomised controlled trial Acupuncture prophylaxis of migraine no better than sham acupuncture for decreasing frequency

Evidence-Based Medicine (Requires free registration)2013

84. Percutaneous Closure of Patent Foramen Ovale for the Treatment of Refractory Migraine Headaches

Percutaneous Closure of Patent Foramen Ovale for the Treatment of Refractory Migraine Headaches "Percutaneous Closure of Patent Foramen Ovale for the Treatment of Refr" by Kristina Anderson < > > > > > Title Author Date of Award 8-10-2013 Degree Type Capstone Project Degree Name Master of Science in Physician Assistant Studies Rights . Abstract Background: Migraine headaches both with and without aura vary in frequency, duration and intensity, affecting the quality of life of up to 10 (...) % of the total population. Migraines are treated with both prophylactic and acute medications. Patent foramen ovale (PFO) is one likely cause of migraine headaches and this is present in up to 25% of the total population. Percutaneous PFO closure is a likely option for definitive treatment for migraine. Once proven refractory to medical treatment, do patients with PFO and migraine respond to percutaneous PFO closure to reduce the frequency, duration and intensity of migraine headaches? Methods: An exhaustive

Pacific University EBM Capstone Project2013

85. Headache - assessment

Headache - assessment Headache - assessment - NICE CKS Clinical Knowledge Summaries Share Headache - assessment - Summary Headache is a symptom of many disorders: Primary headache disorders, in which there is no other condition causing the headache, include the common conditions migraine and tension-type headache, and less common conditions such as cluster headache. Secondary headache disorders, in which another condition causes the headache, include serious conditions such as intracranial (...) neoplasm, meningitis, and subarachnoid haemorrhage and less serious conditions such as sinusitis, mild systemic infection and medication overuse headache. Diagnosis involves: Firstly, assessing for symptoms of secondary causes of headache, starting with conditions that require immediate or urgent referral before considering less serious secondary causes including medication over-use headache. Then, if a secondary cause for headache has been excluded, assessing for the primary headache disorders

NICE Clinical Knowledge Summaries2013

89. Triptans for migraine headaches: a review of clinical evidence on safety

Triptans for migraine headaches: a review of clinical evidence on safety Triptans for migraine headaches: a review of clinical evidence on safety Triptans for migraine headaches: a review of clinical evidence on safety CADTH Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation CADTH. Triptans for migraine headaches: a review of clinical

Health Technology Assessment (HTA) Database.2012

90. Occipital nerve stimulation for chronic cluster headache and chronic migraine headache

Occipital nerve stimulation for chronic cluster headache and chronic migraine headache Occipital nerve stimulation for chronic cluster headache and chronic migraine headache Occipital nerve stimulation for chronic cluster headache and chronic migraine headache Record Status This is a bibliographic record of a published health technology assessment. No evaluation of the quality of this assessment has been made for the HTA database. Citation Occipital nerve stimulation for chronic cluster (...) headache and chronic migraine headache. Lansdale: HAYES, Inc.. Directory Publication. 2012 Authors' conclusions Occipital nerve stimulation (ONS) is a type of peripheral nerve stimulation that has been investigated as a way to treat medically refractory (intractable) headache disorders, including chronic cluster-type headache and migraine headache. The procedure involves the subcutaneous implantation of electrodes and consequent electrical stimulation of the suboccipital region of the scalp

Health Technology Assessment (HTA) Database.2012

91. Review: Prophylactic botulinum toxin A reduces frequency of chronic migraine headaches in adults.

Review: Prophylactic botulinum toxin A reduces frequency of chronic migraine headaches in adults. ACP Journal Club: review: prophylactic botulinum toxin A reduces frequency of chronic migraine headaches in adults. - PubMed - NCBI Warning: The NCBI web site requires JavaScript to function. Search database Search term Search Result Filters Format Summary Summary (text) Abstract Abstract (text) MEDLINE XML PMID List Apply Choose Destination File Clipboard Collections E-mail Order My Bibliography (...) Citation manager Format Create File 1 selected item: 22910964 Format MeSH and Other Data E-mail Subject Additional text E-mail Add to Clipboard Add to Collections Order articles Add to My Bibliography Generate a file for use with external citation management software. Create File 2012 Aug 21;157(4):JC2-10. doi: 10.7326/0003-4819-157-4-201208210-02010. ACP Journal Club: review: prophylactic botulinum toxin A reduces frequency of chronic migraine headaches in adults. 1 , . 1 Kansas University School

Annals of Internal Medicine2012

92. Surgery for treatment of migraine headache

Surgery for treatment of migraine headache Surgery for treatment of migraine headache Surgery for treatment of migraine headache Record Status This is a bibliographic record of a published health technology assessment. No evaluation of the quality of this assessment has been made for the HTA database. Citation Surgery for treatment of migraine headache. Lansdale: HAYES, Inc.. Directory Publication. 2012 Authors' conclusions Surgical deactivation of migraine trigger sites is intended to treat (...) patients with refractory migraine headache disorder that cannot be managed by conventional treatments, and patients who are intolerant of the side effects of conventional treatments. The procedure involves the resection of one or more muscle groups that may be compressing specific nerves causing refractory migraine headache Final publication URL The report may be purchased from: Indexing Status Subject indexing assigned by CRD MeSH Migraine Disorderss; Neurosurgical Procedures Language Published

Health Technology Assessment (HTA) Database.2012

93. The Effectiveness of a Group-Based Acceptance and Commitment Additive Therapy on Rehabilitation of Female Outpatients With Chronic Headache: Preliminary Findings Reducing 3 Dimensions of Headache Impact

The Effectiveness of a Group-Based Acceptance and Commitment Additive Therapy on Rehabilitation of Female Outpatients With Chronic Headache: Preliminary Findings Reducing 3 Dimensions of Headache Impact 22712503 2012 07 04 2012 11 27 2012 07 04 1526-4610 52 7 2012 Jul-Aug Headache Headache The effectiveness of a group-based acceptance and commitment additive therapy on rehabilitation of female outpatients with chronic headache: preliminary findings reducing 3 dimensions of headache impact. 1106 (...) -19 10.1111/j.1526-4610.2012.02192.x Examine whether acceptance and commitment additive therapy is effective in reducing the experience of sensory pain, disability, and affective distress because of chronic headache in a sample of outpatient Iranian females. Chronic headaches have a striking impact on sufferers in terms of pain, disability, and affective distress. Although several Acceptance and Commitment Therapy outcome studies for chronic pain have been conducted, their findings cannot

EvidenceUpdates2012

94. Botulinum toxin a for prophylactic treatment of migraine and tension headaches in adults: a meta-analysis

Botulinum toxin a for prophylactic treatment of migraine and tension headaches in adults: a meta-analysis Botulinum toxin A for prophylactic treatment of migraine and tension headaches in adults: a meta-analysis Botulinum toxin A for prophylactic treatment of migraine and tension headaches in adults: a meta-analysis Jackson JL, Kuriyama A, Hayashino Y CRD summary The authors concluded that botulinum toxin A compared to placebo may be associated with benefit for chronic daily headaches and (...) chronic migraines, but not episodic migraine or chronic tension headaches. Despite some issues with the included trials, which the authors acknowledged, this was a generally thorough analysis and the authors' conclusions seem reasonable and reflect the uncertainty surrounding the evidence. Authors' objectives To assess the effects of botulinum toxin A for prophylactic treatment of migraine and tension headaches in adults. Searching MEDLINE, EMBASE and The Cochrane Library were searched between 1966

DARE.2012

96. Warning: Contraceptive Drugs May Cause Political Headaches.

Warning: Contraceptive Drugs May Cause Political Headaches. Warning: contraceptive drugs may cause political headaches. - PubMed - NCBI Warning: The NCBI web site requires JavaScript to function. Search database Search term Search Result Filters Format Summary Summary (text) Abstract Abstract (text) MEDLINE XML PMID List Apply Choose Destination File Clipboard Collections E-mail Order My Bibliography Citation manager Format Create File 1 selected item: 22417204 Format MeSH and Other Data E-mail (...) Subject Additional text E-mail Add to Clipboard Add to Collections Order articles Add to My Bibliography Generate a file for use with external citation management software. Create File 2012 Apr 12;366(15):1361-4. doi: 10.1056/NEJMp1202701. Epub 2012 Mar 14. Warning: contraceptive drugs may cause political headaches. 1 . 1 School of Law and the School of Medicine and Public Health, University of Wisconsin, Madison, USA. PMID: 22417204 DOI: [Indexed for MEDLINE] Free full text MeSH terms Substance Full

NEJM2012

97. Prophylactic Etoricoxib Is Effective in Preventing "First of Ramadan" Headache: A Placebo-Controlled Double-Blind and Randomized Trial of Prophylactic Etoricoxib for Ritual Fasting Headache.

Prophylactic Etoricoxib Is Effective in Preventing "First of Ramadan" Headache: A Placebo-Controlled Double-Blind and Randomized Trial of Prophylactic Etoricoxib for Ritual Fasting Headache. 21848948 2012 04 10 2012 09 14 2016 11 25 1526-4610 52 4 2012 Apr Headache Headache Prophylactic etoricoxib is effective in preventing "first of Ramadan" headache: a placebo-controlled double-blind and randomized trial of prophylactic etoricoxib for ritual fasting headache. 573-81 10.1111/j.1526 (...) -4610.2011.01993.x Religious fasting is associated with headache. This has been documented as "Yom Kippur headache" and "first of Ramadan headache." Etoricoxib, a Cox-2 inhibitor with a 22-hour half-life, has been shown effective in preventing fasting headache when taken just prior to the 25-hour Yom Kippur fast. We hypothesized that etoricoxib would also be effective in preventing headache during Ramadan, despite the different characteristics of the fast. We performed a double-blind randomized prospective

EvidenceUpdates2012

99. Injection of botulinum toxin (Botox) for prophylaxis of headaches in adults with chronic migraine

Injection of botulinum toxin (Botox) for prophylaxis of headaches in adults with chronic migraine Injection of botulinum toxin (Botox) for prophylaxis of headaches in adults with chronic migraine Injection of botulinum toxin (Botox) for prophylaxis of headaches in adults with chronic migraine Medical Services Advisory Committee Record Status This is a bibliographic record of a published health technology assessment. No evaluation of the quality of this assessment has been made for the HTA (...) database. Citation Medical Services Advisory Committee. Injection of botulinum toxin (Botox) for prophylaxis of headaches in adults with chronic migraine. Canberra: Medical Services Advisory Committee (MSAC). MSAC application 1168. 2012 Authors' conclusions After considering the strength of the available evidence in relation to the safety, clinical effectiveness and cost-effectiveness of injecting botulinum toxin type A (Botox®) in refractory chronic migraine, MSAC supports its public funding via a new

Health Technology Assessment (HTA) Database.2012

100. Botulinum toxin type A for the prevention of headaches in adults with chronic migraine

Botulinum toxin type A for the prevention of headaches in adults with chronic migraine Botulinum toxin type A for the prevention of headaches in adults with chronic migraine | Guidance and guidelines | NICE Botulinum toxin type A for the prevention of headaches in adults with chronic migraine Technology appraisal guidance [TA260] Published date: 27 June 2012 Share Guidance wherever possible. Explore Guidance app Copyright © 2017 National Institute for Health and Care Excellence. All rights

National Institute for Health and Clinical Excellence - Technology Appraisals2012